FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
ENDOCRINOLOGY AND DIABETES

Diabetes drugs: metformin, SGLT2, GLP-1 and sulfonylureas.

Mechanism, key side effects and special benefits of each diabetes drug class for Step 1 and Step 2 CK.

Learn each class by mechanism and the signature adverse effect, then match drugs with comorbidities.

Drug classes

  • Metformin: lowers hepatic gluconeogenesis; GI upset, lactic acidosis, vitamin B12 deficiency; no hypoglycemia, weight neutral.
  • Sulfonylureas: close K-ATP channels, stimulate insulin release; hypoglycemia and weight gain.
  • Thiazolidinediones (pioglitazone): PPAR-gamma; fluid retention, heart failure, fractures.
  • DPP-4 inhibitors: increase incretins; pancreatitis risk.
  • GLP-1 agonists: weight loss, cardiovascular benefit; nausea, pancreatitis, thyroid C-cell tumor warning.
  • SGLT2 inhibitors: glucosuria; genital yeast infections, euglycemic ketoacidosis, benefit in heart failure and kidney disease.

Choosing

Pick GLP-1 agonists or SGLT2 inhibitors for atherosclerotic disease, heart failure or chronic kidney disease. Insulin is used for type 1, pregnancy and severe hyperglycemia.

Keep going in endocrinology and diabetes

Related on USMLE WEB

Frequently asked questions

Which drug causes lactic acidosis?

Metformin, especially in kidney failure.

Which drug class causes euglycemic ketoacidosis?

SGLT2 inhibitors.